Mucoadhesive polymers have recently gained interest among pharmaceutical scientists as a means of improving drug delivery by promoting dosage form residence time and contact time with the mucous membranes. Mucoadhesion occurs between two surfaces, one of which is a mucous membrane and another is drug delivery system. Pharmaceutical aspects of mucoadhesion have been the subject of great interest during recent years because mucoadhesion could be a solution for bioavailability problems that result from a too short length of stay of the pharmaceutical dosage form at the absorption site within the gastro-intestinal tract. It has been a great challenge to the pharmaceutical sciences in order to enhance localised drug delivery or to deliver 'difficult' molecules (proteins and oligonucleotides) into the systemic circulation. Mucoadhesive systems remain in close contact with the absorption tissue, the mucous membrane, releasing the drug at the site of action leading to increase in bioavailability (both local and systemic effects). Extending the residence time of a dosage form at a particular site and controlling the release of drug from the dosage form are useful especially for achieving controlled plasma level of the drug as well as improving bioavailability. The present review describes mucoadhesion, mucoadhesive polymers and use of these polymers in designing different types of mucoadhesive drug delivery systems.
INTRODUCTION
Mucoadhesives are synthetic or natural polymers that interact with the mucous layer covering mucosal epithelial surface, main molecules constituting a major part of mucus (Patil et al., 2006) . Mucoadhesion is a topic of current interest in the design of drug delivery systems (Asane, 2007) . Mucoadhesion is the relatively new and emerging concept in drug delivery. Mucoadhesion keeps the delivery system adhering to the mucous membrane (Semalty, 2006) . Mucoadhesion can be defined as the ability of synthetic or biological macromolecules to adhere to mucosal tissues. It is the ability of a material (synthetic or biological) to adhere to a biological tissue for an extended period of time to improve and enhance the bioavailability of drugs (Bhatt, 1998) . In case of mucoadhesion, the biological tissue is the mucous membrane (Patil et al., 2006) . The first stage involves an intimate contact between a mucoadhesive polymer and a membrane, either from good wetting of the mucoadhesive surface or from the swelling of the mucoadhesive. In the second stage, after contact is established, penetration of the mucoadhesive into the crevice of the tissue surface or interpenetration of the chains of the mucoadhesive with those of the mucous takes place. The third stage involves formation of chemical bonds between the entangled chains (Bhatt, 2009; Aidoo, 2008; Smart, 2005; Hagerstrom, 2006 , Sharma et al., 2009 . 
MUCOADHESIVE POLYMERS
Polymer is a generic term used to describe a very long molecule consisting of structural units and repeating units connected by covalent chemical bonds. The term is derived from the Greek words: polys meaning 'many' and meros meaning 'parts' (Punitha and Girish, 2010) . A polymer is a substance formed by the linkage of a large number of small molecules known as monomers. Mucoadhesive polymers are watersoluble and water insoluble polymers, which have swellable networks, jointed by crosslinking agents. These polymers possess optimal polarity to make sure that they permit sufficient wetting by the mucous and optimal fluidity that permits the mutual adsorption and interpenetration of polymer and mucous takes place (Roy et al., 2006) .
CLASSIFICATION OF POLYMERS
The polymers can be classified based on source (Table 1) , solubility (Table 2) , charge (Table 3) and bioadhesive forces (Table 4) . Depending upon source (Chickering et al., 1996; Punitha and Girish, 2010) A. Natural Polymers B. Synthetic Polymers Depending upon aqueous solubility (Semalty, 2006; Roy et al., 2006) A Table 5 . Order of mucoadhesive force for various polymers (Roy et al., 2010; Hunt et al., 1987; Abnawe, 2009 
PERMEATION ENHANCERS
Substances that facilitate the permeation through mucosa are referred to as permeation enhancers. Membrane permeation is the limiting factor for many drugs in the development of mucoadhesive delivery system. The epithelium that lines the mucosa is a very effective barrier to the absorption of drugs especially buccal mucosa (Chattarajee and Walker, 1995) . The efficacy of enhancer in one site is not same in the other site because of differences in cellular morphology, membrane thickness, enzymatic activity, lipid composition and potential protein interactions are structural and functional properties (Shojaei, 1998) .
Properties
According to Aungst (1994) (Schipper et al., 2004) . 
Inclusion Complexes Cyclodextrins

Thiolated Polymers
Chitosan-4-thiobutylamide, Chitosan-cysteine, Poly (acrylic acid)-homocysteine, Polycarbophil-cysteine, Polycarbophil-cysteine/gsh, Chitosan-4-thioethylamide/gsh,
Chitosan-4-thioglycholic acid
Others Aprotinin, Azone, Cyclodextrin, Dextran sulfate, Menthol, Polysorbate 80 , Sulfoxides and various alkyl glycosides.
